Loading…
World-renowned physicist Stephen Hawking was identified with MND at the age of 21. Photo/IST
It is known that Stephen Hawking was first identified as having MND at the age of 21. There are several types of motor neuron disease, including amyotrophic lateral sclerosis (ALS), progressive bulbar palsy (PBP), progressive muscular atrophy (PMA), and primary lateral sclerosis (PLS).
Stephen Hawking is suspected of suffering from a type of ALS, or what’s often called Lou Gehrig’s disease that makes him paralyzed, so he relies on the use of technology to help him get around. As far as to die at the age of 76 on March 14, 2018, Stephen Hawking is in a paraplegic state.
The findings achieved by Immune Regulation and Immunotherapy scientists at King’s College, England, are believed to hold great hopes for motor neurone disease sufferers to live longer. In research conducted it appears that protein injections used to treat kidney cancer can slow the spread of MND and increase the chances of survival by up to 70%.
Read also: Horrified, archaeologists find 9 crocodile heads planted in ancient Egyptian tombs
“These startling results are a real breakthrough,” said Timothy Tree, professor of immune regulation and immunotherapy at King’s College, quoted by the Daily Mail.
“These findings will be able to make a major change in therapeutic options in treating patients with this devastating disease,” he continued.
The drug was said to be the result of a 21-month study in England and France. The new drug is made from the protein Interleukin-2 (IL-2), which is found in the immune system. The study found that low doses of IL-2 increase the number of certain immune cells in the blood that are capable of fighting inflammatory infections.
Read also: Threat of recession, Apple cancels production of iPhone SE 4
